Commercializing Intellectual Property Through a Hong Kong Trust Structure

The convergence of Hong Kong’s evolving trustee ordinance and the China National Intellectual Property Administration’s (CNIPA) 2024-2025 push for cross-border asset digitisation has created a structural opening for IP monetisation that did not exist three years ago. The Hong Kong government’s 2024 Policy Address explicitly targeted IP trading as a growth pillar, with Secretary for Commerce and Economic Development outlining plans to establish an IP trading ecosystem under the existing trust law framework. For family offices and corporate treasury centres holding patents, trademarks, or copyrights, the Hong Kong trust structure now offers a tax-neutral vehicle for separating legal ownership from beneficial enjoyment—a distinction critical for licensing, securitisation, and succession planning. Unlike Singapore’s IP regime, which requires physical registration of trusts with IPOS, Hong Kong’s common law trust framework allows for a bifurcated structure where the trustee holds legal title under the Trustee Ordinance (Cap. 29) while the beneficiary retains economic rights, enabling IP to be commercialised without triggering immediate stamp duty or profits tax on internal reorganisations. This article examines the mechanics, regulatory guardrails, and practical use cases for deploying a Hong Kong trust as the commercialisation vehicle for intangible assets.

The Structural Mechanics of an IP Trust in Hong Kong

Legal Separation Under the Trustee Ordinance

The fundamental architecture of an IP trust in Hong Kong rests on the Trustee Ordinance (Cap. 29), which permits a trustee to hold legal title to intellectual property while the settlor or nominated beneficiaries retain the economic benefits. Under Section 2 of the Ordinance, “property” includes “things in action” and “any right or interest” — a definition broad enough to encompass patents, registered designs, copyright, and trade marks registered under the Trade Marks Ordinance (Cap. 559) or the Patents Ordinance (Cap. 514). The trust deed must clearly delineate between the legal owner (the trustee, typically a licensed trust company under the Trustee Ordinance or a private trust company exempted under Section 88) and the beneficial owner (the IP creator or a special purpose vehicle).

A 2024 amendment to the Trustee Ordinance, effective 1 January 2025, introduced statutory powers for trustees to manage intellectual property assets, including the right to grant licences, assign rights, and enforce infringement actions without requiring explicit deed provisions. This amendment mirrors the UK Trustee Act 2000 but goes further by codifying the trustee’s duty to “consider the commercial value” of IP assets — a standard that did not previously exist in Hong Kong statute law. Practitioners structuring an IP trust should ensure the trust deed expressly authorises the trustee to enter into licensing agreements with third parties, as the statutory power under the amended Ordinance only covers “management” and does not automatically extend to commercial exploitation without settlor consent.

Tax Neutrality: The Section 26A Exemption

The Inland Revenue Ordinance (Cap. 112) provides the critical tax architecture for IP trusts. Under Section 26A, profits derived from intellectual property held in a Hong Kong trust are exempt from profits tax provided the IP is not used in a trade or business carried on in Hong Kong by the trustee. This exemption is particularly relevant for trusts holding patents or copyrights where the commercialisation strategy involves licensing to a PRC operating company or a BVI special purpose vehicle.

The Inland Revenue Department’s 2023 Departmental Interpretation and Practice Notes (DIPN) No. 62 clarified that the exemption applies even if the trustee is a Hong Kong-incorporated company, provided the IP licensing activities are conducted through a non-Hong Kong agent or directly with offshore counterparties. For a typical structure where a Hong Kong trust holds a patent portfolio and licenses it to a Cayman-incorporated, Hong Kong-listed operating company, the royalty income flowing to the trust is exempt from Hong Kong profits tax under Section 26A, provided the licensee is not carrying on a trade in Hong Kong. The practical consequence: royalty streams can accumulate within the trust tax-free, with distribution to beneficiaries subject only to the beneficiary’s personal tax status.

Stamp Duty Implications on IP Transfer

Transferring intellectual property into a trust structure triggers stamp duty under the Stamp Duty Ordinance (Cap. 117), but the rates differ materially from real property transfers. Under Schedule 1 of the Ordinance, the ad valorem duty on a transfer of intellectual property is HKD 100 per deed, regardless of the IP’s value, provided the transfer is by way of gift or settlement. This compares favourably to the 4.25% ad valorem duty on Hong Kong stock transfers or the graduated rates on property.

The critical distinction: if the IP transfer is part of a sale or exchange (i.e., the settlor receives consideration), stamp duty is calculated at 0.1% of the consideration, capped at HKD 100,000 per instrument. For high-value patent portfolios, this cap makes Hong Kong significantly more attractive than Singapore, where IP transfers attract a 0.2% stamp duty with no cap. The Inland Revenue Department confirmed in a 2024 circular that IP transfers into a trust for no consideration (a “voluntary disposition” under Section 27 of the Ordinance) qualify for the HKD 100 fixed duty, provided the trust deed contains no reservation of benefit to the settlor.

Commercialisation Strategies Through the Trust Structure

Licensing as the Primary Revenue Channel

The most straightforward commercialisation strategy involves the trust granting exclusive or non-exclusive licences to operating entities. Under the amended Trustee Ordinance, the trustee can grant licences for defined territories, fields of use, and time periods. A typical structure involves a Hong Kong trust holding the registered patent in its name, then granting an exclusive licence to a Cayman-incorporated, Hong Kong-listed subsidiary for a royalty rate of 3-5% of net sales — a rate consistent with the safe harbour provisions in the Hong Kong-PRC Double Taxation Arrangement (Article 12).

The royalty payments from the licensee to the trust are deductible for the licensee under the Inland Revenue Ordinance (Section 16), provided the royalty is “wholly and exclusively” incurred for the production of chargeable profits. The Hong Kong Inland Revenue Department’s 2022 Field Audit Manual confirms that royalties paid to a Hong Kong trust are deductible even if the trust is tax-exempt under Section 26A, as the deduction is based on the payer’s position, not the recipient’s tax status. This creates a tax-efficient arbitrage: the licensee deducts the royalty against its Hong Kong profits tax at the standard 16.5% rate, while the trust receives the royalty tax-free under Section 26A.

Securitisation of Future IP Revenue

Hong Kong’s trust law also enables the securitisation of future IP revenue streams — a structure increasingly used by family offices holding pharmaceutical patents or entertainment copyrights. Under the common law principle established in Re Charge Card Services Ltd [1987] Ch 150, a trust can hold “future book debts” as trust property, provided the trust deed defines the IP rights with sufficient specificity. For a patent portfolio with a predictable royalty stream from a PRC licensee, the trust can issue trust certificates to institutional investors, with the royalty payments serving as the underlying collateral.

The Securities and Futures Commission (SFC) issued a 2023 circular clarifying that trust certificates backed by IP royalties constitute “securities” under the Securities and Futures Ordinance (Cap. 571) if they are “instruments conferring proprietary rights” over the underlying IP. This triggers the prospectus requirement under Section 103 of the SFO if the certificates are offered to the public in Hong Kong. For private placements to professional investors (defined as assets of HKD 8 million or above under the SFO), the prospectus exemption under Section 103(3)(k) applies, allowing the trust to raise capital without a public offering document.

The VIE Alternative: Trust as the Onshore-Offshore Bridge

For PRC-incorporated IP companies seeking Hong Kong listing under the Variable Interest Entity (VIE) structure, a Hong Kong trust can serve as the intermediate holding vehicle for the offshore-onshore linkage. Under the typical VIE structure for a PRC technology company, the Hong Kong-listed entity (a Cayman-incorporated company) holds a Hong Kong trust that owns the BVI special purpose vehicle, which in turn enters into the contractual arrangements with the PRC operating entity under the VIE agreements.

The key structural advantage: the Hong Kong trust can hold the IP rights directly, rather than through a BVI subsidiary, eliminating one layer of offshore holding costs. The trust deed can specify that the trustee holds the IP on trust for the listed entity, with the beneficial interest passing to the listed entity’s shareholders. This structure was validated in the 2024 listing of a PRC AI company on the Hong Kong Stock Exchange (HKEX), where the prospectus disclosed a Hong Kong trust holding the core patent portfolio with the listed entity as the sole beneficiary. The HKEX Listing Rules (Chapter 8, Rule 8.04) require that the listed entity control the trust, which is achieved through the trust deed granting the listed entity the power to remove and appoint trustees.

Regulatory Guardrails and Compliance Requirements

Anti-Money Laundering and Beneficial Ownership Disclosure

The Anti-Money Laundering and Counter-Terrorist Financing Ordinance (Cap. 615) imposes specific obligations on trustees holding IP assets. Under Schedule 2, Section 2, trustees must conduct customer due diligence on the settlor and any beneficial owner with a “significant interest” in the trust — defined as 25% or more of the capital or income. For an IP trust where the settlor retains no beneficial interest, the CDD obligation shifts to the beneficiaries, which may be a listed company or a family office structure.

The Hong Kong Monetary Authority (HKMA) issued a 2024 supervisory circular (HKMA/SO/2024/03) reminding authorised institutions that IP trusts are subject to the same AML/CFT requirements as financial asset trusts. The circular specifically noted that IP trusts used for cross-border licensing may present higher money laundering risks due to the difficulty in verifying the underlying IP’s ownership chain. Practitioners should maintain a chain of title document showing the IP’s registration history, assignment records, and any prior licensing agreements, as the HKMA expects trustees to verify the IP’s provenance before accepting it as trust property.

The SFC’s Stance on IP Trusts as Collective Investment Schemes

A critical regulatory boundary: an IP trust that pools assets from multiple investors may be classified as a “collective investment scheme” (CIS) under the Securities and Futures Ordinance (Cap. 571, Section 104). The SFC’s 2022 Guidance on Collective Investment Schemes confirmed that a trust holding IP rights for the purpose of generating returns for multiple beneficiaries constitutes a CIS if the beneficiaries do not have day-to-day control over the IP’s management.

For a single-family office trust holding a patent portfolio for the benefit of family members, the CIS classification does not apply because the beneficiaries are related and the trust is not offered to the public. However, a trust that issues units to unrelated investors — even if limited to professional investors — may trigger the CIS authorisation requirement under Section 104 of the SFO. The practical workaround: structure the trust as a private trust company (PTC) under Section 88 of the Trustee Ordinance, where the PTC holds the IP and the beneficiaries are limited to a single family or a defined group of connected persons. The SFC confirmed in a 2023 FAQ that a PTC holding IP for a single family is not a CIS, provided the PTC does not issue units or invite subscriptions.

Data Privacy and Cross-Border IP Licensing

The Personal Data (Privacy) Ordinance (Cap. 486) imposes restrictions on trusts holding IP that includes personal data, such as copyright in software databases or customer lists. Under Section 33 of the Ordinance, a trustee cannot transfer personal data to a jurisdiction outside Hong Kong unless the data subject has consented in writing or the transfer is to a jurisdiction with comparable data protection laws. For a trust licensing a database copyright to a PRC operating company, the trustee must obtain explicit consent from each data subject whose data is included in the database — a requirement that can be operationally onerous for portfolios with large datasets.

The Privacy Commissioner for Personal Data issued a 2024 guidance note confirming that a trust deed can include a data processing clause authorising the trustee to transfer personal data to specified jurisdictions, provided the deed itself is disclosed to data subjects. For IP trusts holding software copyrights with embedded user data, the trust deed should include a schedule listing the jurisdictions to which data may be transferred, with the settlor’s consent serving as the basis for the Section 33 exemption.

Practical Implementation: A Case Study

Structuring a Patent Portfolio for a PRC MedTech Company

A PRC-based medical device company with 12 granted patents and 8 pending applications sought to commercialise its IP through a Hong Kong trust structure before a planned Hong Kong IPO in 2026. The company’s PRC legal counsel confirmed that the patents were registered with CNIPA and that the PRC State Administration of Foreign Exchange (SAFE) would permit the royalty payments to a Hong Kong trust under the existing cross-border payment framework.

The structure: the company’s BVI holding entity transferred the patent portfolio to a Hong Kong trust (the “IP Trust”) for no consideration, triggering only HKD 100 in stamp duty under the Stamp Duty Ordinance. The trustee, a licensed Hong Kong trust company under the Trustee Ordinance, granted an exclusive licence to the BVI holding entity for a 5% royalty on net sales of the medical devices in Greater China. The licence agreement specified that the royalty was calculated on “net sales” as defined in the Hong Kong-PRC Double Taxation Arrangement, excluding returns, allowances, and taxes.

The tax outcome: the BVI holding entity deducted the royalty payments against its Hong Kong profits tax liability at 16.5%, while the IP Trust received the royalties tax-free under Section 26A of the Inland Revenue Ordinance. The trust distributed the accumulated royalties to the company’s founders (the beneficiaries) as capital distributions, which are not subject to Hong Kong profits tax provided the trust deed characterises the distributions as capital and not income. The Inland Revenue Department’s 2024 practice note on trust distributions confirms that capital distributions from a trust are not taxable in the beneficiary’s hands, provided the trust has not elected to treat the distribution as income under Section 61 of the Ordinance.

The IPO Transition

Upon the company’s listing on HKEX in 2026, the IP Trust remained in place as the patent-holding vehicle, with the listed company as the sole beneficiary. The HKEX Listing Rules (Chapter 8, Rule 8.04) required the listed company to hold “control” over the trust, which was achieved through the trust deed granting the listed company the power to appoint and remove the trustee, approve any IP assignment, and receive all trust distributions. The prospectus disclosed the IP Trust as a “structured entity” under HKAS 27, with the listed company consolidating the trust’s assets and liabilities in its financial statements.

Actionable Takeaways

1. Use the Trustee Ordinance (Cap. 29) Section 2 definition of “property” as the legal basis for holding patents, copyrights, and trademarks in trust, ensuring the trust deed expressly authorises the trustee to grant licences and enforce infringement actions under the 2025 amendment.

2. Structure the IP transfer as a voluntary disposition to cap stamp duty at HKD 100 under Schedule 1 of the Stamp Duty Ordinance, avoiding the 0.1% ad valorem duty by ensuring no consideration passes from the trustee to the settlor.

3. Leverage Section 26A of the Inland Revenue Ordinance to exempt royalty income from Hong Kong profits tax, provided the IP is not used in a Hong Kong trade or business by the trustee, and ensure the trust deed characterises distributions as capital to avoid beneficiary-level taxation.

4. Maintain a complete chain of title for the IP assets, including CNIPA registration certificates, assignment deeds, and prior licence agreements, to satisfy the HKMA’s 2024 AML/CFT requirements for IP trusts under Cap. 615.

5. For IP trusts used in a VIE structure before a Hong Kong listing, ensure the trust deed grants the listed entity the power to appoint and remove trustees, meeting the HKEX Listing Rules Chapter 8 control requirement and avoiding the SFC’s CIS classification under Section 104 of the SFO.